India's antibiotic resistance crisis is a ticking time bomb
India's antibiotic resistance crisis isn't just a medical issue, it's a ticking time bomb fueled by policy gaps and easy access.
The "candy store" approach to medicine
In many parts of India, buying a strip of Azithromycin is often easier than buying a train ticket, no questions, no prescription. While we treated antibiotics like over-the-counter candy for minor viral flus, the bacteria were busy evolving. Per the WHO's GLASS 2025 report, India is now a primary contributor to the global Antimicrobial Resistance (AMR) burden. A 2025 Lancet study revealed 83% of Indian patients carried multidrug-resistant organisms, compared to just 10% in the Netherlands. We're staring at a future where a simple scratch or routine surgery could become a death sentence.
The human cost
newborns die annually in India from sepsis caused by drug-resistant bacteria (NAMS).
of Indian patients carried multidrug-resistant organisms (2025 Lancet).
projected AMR-related deaths by 2050 if uncontrolled.
Why is this happening?
It's not just doctors prescribing too much (though Azithromycin and Ofloxacin are massively overprescribed), it's a systemic failure on multiple fronts. The "just in case" culture: patients demand antibiotics for viral fevers, pharmacists dispense to keep business flowing. The agricultural loophole: Colistin, a last-hope antibiotic for humans, still finds its way into poultry feed as a growth promoter, creating environmental reservoirs of resistance. And sanitation blindspots: hospital effluents dump active pharmaceutical ingredients into waterways, teaching environmental bacteria how to survive our drugs.
The bright spot: the Kerala model
Through Operation AMRITH (launched January 2024), Kerala cracked down on OTC sales, suspending pharmacy licenses and conducting surprise raids, and introduced the "Antibiotic Smart Hospital" initiative focused on community literacy. The result: a reported 20–30% drop in antibiotic sales and a modest decline in resistance rates. It proves the beast can be tamed.
The way forward
India's National Action Plan 2.0 (NAP-AMR) has a significant focus on "One Health" and surveillance. But without enforcement, a plan is just a PDF. We need strict enforcement (the "red line" on medicine strips must mean something, with real penalties for prescription-free sales), better diagnostics (rapid tests so doctors stop guessing and start targeting), and stewardship (medical colleges teaching when not to prescribe, as much as when to).
Antibiotics are a non-renewable resource. We've used them with the reckless abandon of a gambler on a winning streak. But the house always wins, and in this case, the house is the bacteria.